Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SCAGLIONE, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.212
EU - Europa 4.661
AS - Asia 3.517
SA - Sud America 623
Continente sconosciuto - Info sul continente non disponibili 448
AF - Africa 72
OC - Oceania 8
Totale 18.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.040
IT - Italia 1.325
SG - Singapore 1.163
CN - Cina 979
RU - Federazione Russa 955
FI - Finlandia 553
BR - Brasile 469
UA - Ucraina 372
DE - Germania 366
HK - Hong Kong 359
VN - Vietnam 329
IE - Irlanda 236
PL - Polonia 217
GB - Regno Unito 194
FR - Francia 183
BD - Bangladesh 141
JP - Giappone 93
KR - Corea 85
SE - Svezia 85
CA - Canada 83
IN - India 66
TR - Turchia 52
MX - Messico 42
AR - Argentina 39
NL - Olanda 37
PK - Pakistan 28
CO - Colombia 26
ID - Indonesia 26
BE - Belgio 25
EC - Ecuador 24
IQ - Iraq 24
RO - Romania 23
VE - Venezuela 23
CL - Cile 19
PH - Filippine 19
AT - Austria 18
MY - Malesia 18
ES - Italia 17
NP - Nepal 17
ZA - Sudafrica 16
UZ - Uzbekistan 15
IR - Iran 13
MA - Marocco 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 11
CI - Costa d'Avorio 10
AL - Albania 9
CH - Svizzera 9
CR - Costa Rica 9
JO - Giordania 8
PY - Paraguay 8
AU - Australia 7
AZ - Azerbaigian 7
BG - Bulgaria 7
HN - Honduras 7
IL - Israele 7
EG - Egitto 6
MK - Macedonia 6
PE - Perù 6
TH - Thailandia 6
BO - Bolivia 5
JM - Giamaica 5
AO - Angola 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
GE - Georgia 4
GT - Guatemala 4
KZ - Kazakistan 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BF - Burkina Faso 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
GP - Guadalupe 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
Totale 18.079
Salva come PNG Salva come JPEG
Città #
Ashburn 995
Fairfield 865
Singapore 772
San Jose 612
Woodbridge 495
Chandler 485
Houston 392
Seattle 359
Wilmington 350
Hong Kong 349
Cambridge 284
Ann Arbor 283
Dublin 235
Palermo 235
Council Bluffs 226
Zgierz 186
Jacksonville 179
Beijing 160
Moscow 153
Medford 142
Santa Clara 141
Des Moines 136
Ho Chi Minh City 121
Los Angeles 118
Boardman 115
New York 115
Altamura 103
Nanjing 100
Princeton 92
Tokyo 89
Frankfurt am Main 88
Lauterbourg 84
Dallas 80
Helsinki 79
Hanoi 78
Milan 72
San Diego 70
Lawrence 69
Buffalo 60
Hefei 57
Rome 57
Dearborn 55
Tulsa 53
Hebei 49
Jinan 46
Shenyang 46
Springfield 43
The Dalles 43
Chicago 41
Columbus 41
São Paulo 41
Phoenix 38
Izmir 34
Nanchang 34
Tianjin 33
London 31
Changsha 30
Atlanta 28
San Mateo 26
Brussels 23
Naples 23
Kumar 22
Ottawa 22
Da Nang 21
Florence 21
Seongnam 20
Amsterdam 19
Düsseldorf 19
Verona 19
Auburn Hills 18
Jiaxing 18
Orem 18
Guangzhou 17
Toronto 17
Denver 16
Ningbo 16
San Francisco 15
Taizhou 15
Zhengzhou 15
Baghdad 14
Brooklyn 14
Falls Church 14
Munich 14
Nuremberg 13
Rio de Janeiro 13
Santiago 13
Shanghai 13
Turin 13
Fort Worth 12
Haiphong 12
Ludwigshafen am Rhein 12
Saint Petersburg 12
Belo Horizonte 11
Brasília 11
Grassobbio 11
Hangzhou 11
Kraków 11
Mumbai 11
Philadelphia 11
Prineville 11
Totale 11.024
Salva come PNG Salva come JPEG
Nome #
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 611
Obesità e rischio cardiovascolare. 589
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 337
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 310
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 307
A meta-analysis of the effect size of rheumatoid arthritis on left ventricular mass: comment on the article by Rudominer et al 296
Advice for health-care professionals on how to retrieve more efficiently scientifically strong and up-to-date studies on treatments by PubMed. 280
Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. 280
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 265
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. 262
L’obesità fattore o co-fattore di rischio? 254
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 251
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 245
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 244
Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study. 241
Association between low education and higher global cardiovascular risk 241
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 235
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 232
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 226
Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era. 225
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 224
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 223
Surgery during etanercept therapy in patients with rheumatoid arthritis: is it time to follow patient preferences? 220
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects 220
Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. 219
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 218
The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. 216
Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease 214
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 211
Education and hypertension: impact on global cardiovascular risk 210
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 209
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 209
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 207
Optimized search strategy for detecting scientifically strong studies on treatment through PubMed 204
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 201
Cardiovascular Events in Rheumatoid Arthritis - Time to See beyond Articular Involvement in "real World" Clinical Practice: Comment on the Article by Mackey et al 201
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 199
Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: randomized controlled trial versus hydrochlorothiazide. 199
Visceral obesity and metabolic syndrome: two faces of the same medal? 197
Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease 196
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 194
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 194
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 192
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function 191
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 187
Polymyalgia rheumatica and vertebral fractures: a 1-year pilot controlled study 187
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 186
Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 185
Heart involvement in Rheumatoid Arthritis: Systematic review and meta-analysis. 182
Analysis of 24-h noninvasive ambulatory blood pressure profiles by a third-degree polynomial approach 181
No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis. 180
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 180
Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions on treatment? 179
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 177
Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy 177
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 174
Ultrasonography NAFLD subclinical carotid atherosclerosis and inflammatory markers in patients with and without metabolic syndome. 173
Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari 173
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 172
Evidence-based practice needs stronger prognostic scores for the prediction of recurrent stroke. 172
Obesity, hypertension and atherosclerosis 169
Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familare(FH) con pregresso IMA e/o Lesione carotidea 167
Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for assessing low or very low ejection fraction values? 167
Sindrome metabolica oggi: che cosa c’è da sapere, che cosa c’è da fare. 163
Obesity: a main factor of metabolic syndrome? 163
Haemostatic and fibrinolytic abnormalities in obese patients and in patients with type 2 diabetes with metabolic syndrome 162
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia 162
Evaluation of regional haemodynamics and alterations of vascu¬lar wall of the lower limbs in hypertensive subjects 161
Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo. Eur J Clin Pharmacol 157
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 155
Left ventricular diastolic filling alterations in subjects with mitral valve prolapse: a Doppler echocardiographic study 153
Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. 153
Non-alcoholic fatty liver disease: Severity of fibrosis and its relationships with clinical and biological variables 150
Effects of a short-term hypoenergetic diet on morphofunctional left ventricular parameters in centrally obese subjects 148
Nutrizione,sovrappeso e sindrome metabolica 146
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 145
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 144
Iperuricemia: significato clinico e nuove prospettive di trattamento 143
Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. 141
Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. 132
Obesità, Diabete e Rischio Cardiovascolare. 130
Sindrome Metabolica 123
Obesity and cardiovascular diseases. 123
La terapia dietetica nell’insufficienza renale cronica. 122
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 119
Scompenso cardiaco da disfunzione diastolica. 115
Sindrome metabolica: fatti e compromessi. 113
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 104
Il paziente iperteso ad alto rischio cadiovascolare 102
Therapeutic management of elderly hypertensives with concomitant ischaemic heart disease. 101
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 100
Prevalence of pericardial effusion in subjects with rheumatoid arthritis: an echocardiographic study 92
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 90
Transforming growth factor ß1 ed effetto nefroprotettivo dell’associazione ACE-inibitore/ AT1 antagonista in soggetti ipertesi con iniziale danno renale. 87
Effect of obesity on left ventricular function studied by radionuclide angiocardiography. 82
null 51
null 42
Totale 18.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022827 0 0 20 49 36 33 81 55 133 144 90 186
2022/20231.469 126 279 34 145 158 222 115 100 173 15 60 42
2023/2024585 31 85 30 37 43 105 41 43 8 14 17 131
2024/20251.567 34 122 70 172 45 37 92 101 114 175 202 403
2025/20265.917 391 140 269 399 472 869 913 650 366 816 287 345
2026/20271.415 456 394 565 0 0 0 0 0 0 0 0 0
Totale 18.541